Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-08

Clinical Trial Update: Effectiveness and Safety of Guilu Erxian Oral Liquid in the Treatment of Oligozoospermia and Asthenospermia With Syndrome of Shen (Kidney) Essence Deficiency [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the effectiveness and safety of Guilu Erxian Oral Liquid for men with oligozoospermia and/or asthenospermia in the context of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guilu Erxian Oral Liquid

Snippet

Sponsor: DongE E Jiao Coporation Limited | Conditions: Mild and Moderate Oligozoospermia Asthenospermia or Oligoasthenospermia and the Syndrome Differentiation Type is Shen (Kidney) Essence Deficiency | Phase 4 | Status: COMPLETED